Artículos por temáticas

Gap detection deficits in humans with tinnitus as assessed with the acoustic startle paradigm: does tinnitus fill in the gap?

Fournier P, Hébert S.

Hear Res. 2013 Jan;295:16-23. doi: 10.1016/j.heares.2012.05.011.

Identification of COL6A2 mutations in progressive myoclonus epilepsy syndrome.

Karkheiran S, Krebs CE, Makarov V, Nilipour Y, Hubert B, Darvish H, Frucht S, Shahidi GA, Buxbaum JD, Paisán-Ruiz C.

Hum Genet. 2013 Mar;132(3):275-83. doi: 10.1007/s00439-012-1248-1.

Differential effects of subchronic phencyclidine on anxiety in the light-enhanced startle-, light/dark exploration- and open field tests.

Enkel T, Thomas M, Bartsch D.

Behav Brain Res. 2013 Apr 15;243:61-5. doi: 10.1016/j.bbr.2012.12.060.

Response to correspondence on active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome.

Tate ED, Pranzatelli MR.

J Child Neurol. 2013 Mar;28(3):417-8. doi: 10.1177/0883073812469054. No abstract available.

Peri-adolescent ethanol vapor exposure produces reductions in hippocampal volume that are correlated with deficits in prepulse inhibition of the startle.

Ehlers CL, Oguz I, Budin F, Wills DN, Crews FT.

Alcohol Clin Exp Res. 2013 Sep;37(9):1466-75. doi: 10.1111/acer.12125.

EMG-guided salpingopharyngeus Botox injection for palatal myoclonus.

Wan TK, Chen JT, Wang PC.

B-ENT. 2013;9(1):67-9.

Moderate-level prenatal alcohol exposure enhances acoustic startle magnitude and disrupts prepulse inhibition in adult rhesus monkeys.

Schneider ML, Larson JA, Rypstat CW, Resch LM, Roberts A, Moore CF.

Alcohol Clin Exp Res. 2013 Oct;37(10):1729-36. doi: 10.1111/acer.12151.

White matter degeneration with Unverricht-Lundborg progressive myoclonus epilepsy: a translational diffusion-tensor imaging study in patients and cystatin B-deficient mice.

Manninen O, Koskenkorva P, Lehtimäki KK, Hyppönen J, Könönen M, Laitinen T, Kalimo H, Kopra O, Kälviäinen R, Gröhn O, Lehesjoki AE, Vanninen R.

Radiology. 2013 Oct;269(1):232-9. doi: 10.1148/radiol.13122458.

Clinical characteristics and therapeutic response of objective tinnitus due to middle ear myoclonus: a large case series.

Park SN, Bae SC, Lee GH, Song JN, Park KH, Jeon EJ, Park YS, Yeo SW.

Laryngoscope. 2013 Oct;123(10):2516-20. doi: 10.1002/lary.23854.

Atypical antipsychotic olanzapine reversed deficit on prepulse inhibition of the acoustic startle reflex produced by microinjection of dizocilpine (MK-801) into the inferior colliculus in rats.

Zangrando J, Carvalheira R, Labbate G, Medeiros P, Longo BM, Melo-Thomas L, Silva RC.

Behav Brain Res. 2013 Nov 15;257:77-82. doi: 10.1016/j.bbr.2013.09.018.

Mucolipidosis and progressive myoclonus epilepsy: a distinctive phenotype.

Menon RN, Jagtap S, Thakkar R, Narayanappa G, Nair M.

Neurol India. 2013 Sep-Oct;61(5):537-9. doi: 10.4103/0028-3886.121943. No abstract available.

PAC1 receptor (ADCYAP1R1) genotype is associated with dark-enhanced startle in children.

Jovanovic T, Norrholm SD, Davis J, Mercer KB, Almli L, Nelson A, Cross D, Smith A, Ressler KJ, Bradley B.

Mol Psychiatry. 2013 Jul;18(7):742-3. doi: 10.1038/mp.2012.98. No abstract available.

A unique case of peripheral myoclonus.

Ross Russell AL, Knight W, Oware A, Fuller GN.

J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):117-8. doi: 10.1136/jnnp-2012-303795. No abstract available.

A novel SCARB2 mutation causing late-onset progressive myoclonus epilepsy.

Higashiyama Y, Doi H, Wakabayashi M, Tsurusaki Y, Miyake N, Saitsu H, Ohba C, Fukai R, Miyatake S, Joki H, Koyano S, Suzuki Y, Tanaka F, Kuroiwa Y, Matsumoto N.

Mov Disord. 2013 Apr;28(4):552-3. doi: 10.1002/mds.25296. No abstract available.

Progressive encephalomyelitis with rigidity and myoclonus: a syndrome with diverse clinical features and antibody responses.

Shugaiv E, Leite MI, Şehitoğlu E, Woodhall M, Çavuş F, Waters P, İçöz S, Birişik Ö, Uğurel E, Ulusoy C, Kürtüncü M, Vural B, Vincent A, Akman-Demir G, Tüzün E.

Eur Neurol. 2013;69(5):257-62. doi: 10.1159/000342237.